SARS-CoV-2 infection in pregnant women and their newborns

Melanie Etti; Musa Sekikubo; Victoria Nankabirwa; Halvor Sommerfelt; Bridget Freyne; Kondwani Kawaza; Gladys Gadama; Kondwani Jambo; Esperança Sevene; Marleen Temmerman; Laura A. Magee; Peter von Dadelszen; Asma Khalil; Kirsty Le Doare

doi:10.5334/aogh.3072

SARS-CoV-2 infection in pregnant women and their newborns

Melanie Etti, Musa Sekikubo, Victoria Nankabirwa, Halvor Sommerfelt, Bridget Freyne, Kondwani Kawaza, Gladys Gadama, Kondwani Jambo, Esperança Sevene, Marleen Temmerman, Laura A. Magee, Peter von Dadelszen, Asma Khalil, Kirsty Le Doare

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Abstract

There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harness-ing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.

Original language	English
Article number	132
Pages (from-to)	1-3
Number of pages	3
Journal	Annals of Global Health
Volume	86
Issue number	1
DOIs	https://doi.org/10.5334/aogh.3072
Publication status	Published - 1 Jan 2020
Externally published	Yes

Access to Document

10.5334/aogh.3072Licence: CC BY

Cite this

@article{92a384765bf047d6a78c256f993e936f,

title = "SARS-CoV-2 infection in pregnant women and their newborns",

abstract = "There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harness-ing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.",

author = "Melanie Etti and Musa Sekikubo and Victoria Nankabirwa and Halvor Sommerfelt and Bridget Freyne and Kondwani Kawaza and Gladys Gadama and Kondwani Jambo and Esperan{\c c}a Sevene and Marleen Temmerman and Magee, \{Laura A.\} and \{von Dadelszen\}, Peter and Asma Khalil and Doare, \{Kirsty Le\}",

year = "2020",

month = jan,

day = "1",

doi = "10.5334/aogh.3072",

language = "English",

volume = "86",

pages = "1--3",

journal = "Annals of Global Health",

issn = "1931-7581",

publisher = "Ubiquity Press",

number = "1",

}

TY - JOUR

T1 - SARS-CoV-2 infection in pregnant women and their newborns

AU - Etti, Melanie

AU - Sekikubo, Musa

AU - Nankabirwa, Victoria

AU - Sommerfelt, Halvor

AU - Freyne, Bridget

AU - Kawaza, Kondwani

AU - Gadama, Gladys

AU - Jambo, Kondwani

AU - Sevene, Esperança

AU - Temmerman, Marleen

AU - Magee, Laura A.

AU - von Dadelszen, Peter

AU - Khalil, Asma

AU - Doare, Kirsty Le

PY - 2020/1/1

Y1 - 2020/1/1

N2 - There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harness-ing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.

AB - There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harness-ing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.

U2 - 10.5334/aogh.3072

DO - 10.5334/aogh.3072

M3 - Letter

SN - 1931-7581

VL - 86

SP - 1

EP - 3

JO - Annals of Global Health

JF - Annals of Global Health

IS - 1

M1 - 132

ER -

SARS-CoV-2 infection in pregnant women and their newborns

Abstract

Access to Document

Fingerprint

Cite this